Long‐term outcome of urea cycle disorders: Report from a nationwide study in Japan

高氨血症 尿素循环 鸟氨酸转氨酶缺乏症 鸟氨酸转氨酶 精氨琥珀酸合成酶 医学 精氨琥珀酸裂解酶 肝移植 儿科 内科学 精氨酸酶 氨甲酰磷酸合成酶 移植 生物 精氨酸 基因 氨基酸 生物化学
作者
Jun Kido,Shirou Matsumoto,Johannes Häberle,Yoko Nakajima,Yoichi Wada,Narutaka Mochizuki,Kei Murayama,Tomoko Lee,Hidetaka Mochizuki,Yoriko Watanabe,Reiko Horikawa,Mureo Kasahara,Kimitoshi Nakamura
出处
期刊:Journal of Inherited Metabolic Disease [Springer Science+Business Media]
卷期号:44 (4): 826-837 被引量:19
标识
DOI:10.1002/jimd.12384
摘要

Urea cycle disorders (UCDs) are inherited metabolic disorders with impaired nitrogen detoxification caused by defects in urea cycle enzymes. They often manifest with hyperammonemic attacks resulting in significant morbidity or death. We performed a nationwide questionnaire-based study between January 2000 and March 2018 to document all UCDs in Japan, including diagnoses, treatments, and outcomes. A total of 229 patients with UCDs were enrolled in this study: 73 males and 53 females with ornithine transcarbamylase deficiency (OTCD), 33 patients with carbamoylphosphate synthetase 1 deficiency, 48 with argininosuccinate synthetase deficiency, 14 with argininosuccinate lyase deficiency, and 8 with arginase deficiency. Survival rates at 20 years of age of male and female patients with late-onset OTCD were 100% and 97.7%, respectively. Blood ammonia levels and time of onset had a significant impact on the neurodevelopmental outcome (P < .001 and P = .028, respectively). Hemodialysis and liver transplantation did not prevent poor neurodevelopmental outcomes. While treatment including medication, hemodialysis, and liver transplantation may aid in decreasing blood ammonia and/or preventing severe hyperammonemia, a blood ammonia level ≥ 360 μmol/L was found to be a significant indicator for a poor neurodevelopmental outcome. In conclusion, although current therapy for UCDs has advanced and helped saving lives, patients with blood ammonia levels ≥ 360 μmol/L at onset often have impaired neurodevelopmental outcomes. Novel neuroprotective measures should therefore be developed to achieve better neurodevelopmental outcomes in these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lwm不想看文献完成签到 ,获得积分10
刚刚
2秒前
拼搏一曲发布了新的文献求助10
3秒前
CAOHOU应助科研通管家采纳,获得10
4秒前
共享精神应助科研通管家采纳,获得10
4秒前
CAOHOU应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得20
4秒前
乐乐应助科研通管家采纳,获得10
4秒前
汉堡包应助科研通管家采纳,获得10
4秒前
FashionBoy应助科研通管家采纳,获得10
4秒前
桐桐应助科研通管家采纳,获得10
4秒前
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
CAOHOU应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得10
4秒前
CAOHOU应助科研通管家采纳,获得10
4秒前
Owen应助科研通管家采纳,获得10
5秒前
SYLH应助科研通管家采纳,获得10
5秒前
SYLH应助科研通管家采纳,获得10
5秒前
5秒前
酷波er应助科研通管家采纳,获得10
5秒前
wushuwen发布了新的文献求助10
5秒前
6秒前
xuan完成签到,获得积分10
7秒前
完美世界应助段一帆采纳,获得10
9秒前
少敏敏完成签到,获得积分10
11秒前
may发布了新的文献求助10
11秒前
16秒前
18秒前
兜兜关注了科研通微信公众号
18秒前
wbh完成签到,获得积分10
19秒前
太牛的GGB发布了新的文献求助10
19秒前
wbh发布了新的文献求助10
21秒前
乐乐应助may采纳,获得10
21秒前
顺利的梦菲完成签到 ,获得积分10
22秒前
777完成签到 ,获得积分10
22秒前
上官若男应助忧郁盼夏采纳,获得10
23秒前
冷艳的姿发布了新的文献求助10
24秒前
量子星尘发布了新的文献求助10
26秒前
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173